Belo, a member of PRWeek’s 2024 Health Influencer list, joined Takeda in 2021 as VP and global head of external communications. The company promoted him to SVP and head of global corporate brand and ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires from the ...

currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires from the ...

Wang said ongoing policy measures will strongly support economic growth. China will continue to create favorable conditions ...

The candidate is one of six pipeline drugs that Takeda is hoping will collectively bring in between $10 billion and $20 billion, CEO Christophe Weber said during the company’s J.P. Morgan ...

Takeda has been restructured under new CEO Christophe Weber, who took over in 2014 and has focused the company on cancer and specialist gastrointestinal drugs, and early stage central nervous ...

January 30, 2025 Drugmaker Takeda's CEO Weber to step down, raises profit forecast Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm ...

Takeda will hold an investor vote on its $62 billion acquisition of Shire next month, and aims to close the deal on January 8. Under the leadership of CEO Christophe Weber, Takeda is hoping to ...

Christophe Weber, president, CEO and representative director of Takeda Pharmaceutical Co, expressed a similar opinion. Takeda will make targeted investments in data and digital solutions in China ...

currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires ...

Takeda has announced a $100 million collaboration ... The Japanese pharma company, led by chief executive Christophe Weber, is looking to upgrade its R&D pipeline with some of the best cutting ...